Education, Certifications, Memberships
Bachelor of Medicine, Bachelor of Surgery (M.B.B.S.) – University of Bombay, India, 1983
Doctor of Medicine, Board certified Internal Medicine – University of Bombay, India, 1987
Internal Medicine Residency – BYL Nair Hospital, University of Bombay, India, 1987
Internal Medicine Residency – Interfaith Medical Center, SUNY, Brooklyn,1989
Neurology Residency – University of Illinois at Chicago, 1990
Neurology Residency – University of Iowa, 1992
Clinical Electrophysiology Fellowship (EMG, EEG, EP) – University of Iowa, 1993
Neuromuscular Disorders Fellowship – University of Iowa, 1994
Board Certified, American Board of Psychiatry and Neurology, Adult Neurology
Board Certified, American Association of Neuromuscular & Electrodiagnostic Medicine
Board Certified, American Board of Psychiatry and Neurology, Clinical Neurophysiology
American Academy of Neurology, Certification in Nerve Pathology
Board Certified, American Board of Psychiatry and Neurology, Neuromuscular Medicine
Publications, Directorships, Boards, Additional Positions
Neuromuscular Pathology Examination Committee, United Council for Neurologic Subspecialties (UCNS): 2005-present
Adjunct Associate Professor, University of Minnesota, Minneapolis, Department of Neurology: 2007-present
Associate Professor, University of Iowa, Department of Neurology & Pathology; Director, Neuromuscular Program; Director, ALS Clinic; Associate Director, Neurology Residency Program: 2001-2006
Assistant Professor, University of Minnesota, Minneapolis, Department of Neurology; Director, ALS Clinic; Director, Neurology Residency Program: 1996-2000
P.Kelkar, S. Chang, S. Muley. Response to oral supplementation in copper deficiency myeloneuropathy. J Clic Neuromuscul Dis, 10:1-3, 2008.
S. Muley, P.Kelkar, G. Parry. Treatment of Chronic Inflammatory Demyelinating Polyneuropathy with Pulsed Oral Steroids, Arch Neurol.65(11):1460-1464, 2008.
S. Chahin, M. Garwood, E. St Louis, E. Shivapour, P. Kelkar, M. Granner. Intramedullary Sjogren’s Syndrome, Neurology, Neurology 73;2041-2042, 2009.
Parry GJ1, Rodrigues CMP, Aranha MM, Hilbert S, Davey C, Kelkar P, Low WC, Steer CJ. Safety, tolerability and cerebrospinal fluid penetration of ursodeoxycholic acid in patients with amyotrophic lateral sclerosis, Clinical Pharmacology 33(1);17-21, 2010.
P.Kelkar, C. Farmer, A Liu. Natalizumab efficacy in a clinical practice setting with multiple sclerosis patients – a retrospective, single-center study in a community neurology clinic. The 63rd Annual Meeting of the American Academy of Neurology, Honolulu, April 2011.